Target intelligence / Profile preview

T cell receptor alpha variable 33 (pseudogene) (TRAV33)

Target
TRAV33
Molecular classification
Pseudogene, Immunoglobulin superfamily
01

Overview

T cell receptor alpha variable 33 (TRAV33) is a segment within the T cell receptor alpha (TRA) locus, labeled as a **pseudogene** in the human genome[1]. The TRA locus contains variable (V), joining (J), and constant (C) gene segments that undergo somatic recombination to create diversity in the antigen recognition domains of T cell receptors. However, several V and J segments are incapable of coding for functional proteins and are deemed pseudogenes. TRAV33 is one of these nonproductive segments and does not participate directly in forming functional T cell receptor proteins[1]. As such, it currently has no established role in physiology, immune response, or disease, and is not considered a therapeutic target.

Other names
C14orf12TCRAV33S1TRAV33
02

Mechanism of action

Not applicable

03

Biological functions

None (as a pseudogene, it does not encode a functional protein)
04

Disease associations

None established; not implicated in disease as a target
05

Safety considerations

None specific or relevant (not pharmaceutically targeted)

Beyond the preview

Go deeper on T cell receptor alpha variable 33 (pseudogene) (TRAV33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 33 (pseudogene) (TRAV33).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call